secwatch.observer — SEC 8-K summary
======================================

Issuer:     NutriBand Inc. (NTRB)
CIK:        0001676047
Form:       8-K
Filed at:   2023-07-14T23:59:59+00:00
Accession:  0001213900-23-056939
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutriband replaces $2M credit line with $5M facility at 7% for AVERSA Fentanyl
------------------------------------------------------------------------------

- Secured $5M credit line at 7% interest, maturing July 13, 2026, replacing prior $2M facility.
- Funds for AVERSA™ Fentanyl FDA approval and commercial manufacturing via Kindeva Drug Delivery.
- No conversion rights; advances contingent on starting Kindeva work related to NDA filing.
- Interest payable annually each Dec 31 starting 2023; prepayment allowed without penalty.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676047/000121390023056939/0001213900-23-056939-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676047/000121390023056939/ea181821-8k_nutriband.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-056939

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer